Salvianolic Acid A From Salvia miltiorrhiza Suppresses Endometrial Carcinoma Progression via CD40 ‐ AKT ‐ NF ‐ κB Pathway
Scandinavian Journal of Immunology · 2025
DOI: 10.1111/sji.70017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2025. Verfasst von Chunhua Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, Macau University of Science and Technology, Macau, China. Hauptthemen laut MEDLINE: Salvia miltiorrhiza, Endometrial Neoplasms, CD40 Antigens, Caffeic Acids. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Macau University of Science and Technology Research Fund.
Abstract (Originalsprache)
We aimed to investigate the effects of Salvianolic acid A (SA), an active ingredient of Salvia miltiorrhiza Bunge, on the proliferation, metastasis and CD40‐AKT‐NF‐κB signalling pathway in endometrial carcinoma (EC). Human EC cell lines (Ishikawa and HEC‐1A) were treated with varying concentrations of SA, CD40 soluble ligand (sCD40L) or a combination of both. Cell viability, proliferation, invasion and migration were assessed using MTT, colony formation and transwell assays. Flow cytometry was used to analyse apoptosis and cell cycle progression. qRT‐PCR evaluated the mRNA level of CD40. The protein expression of CD40, p‐AKT, p‐mTOR, p‐p65, and p52 was evaluated via Western blot and immunofluorescence. A subcutaneous tumour model was used to examine the impact of SA on tumour growth, followed by immunohistochemical analysis of Ki‐67, CD40, p‐AKT and p‐mTOR. SA treatment reduced EC cell viability, proliferation, invasion and migration, while also triggering apoptosis and inducing cell cycle arrest in the G0/G1 phase in a dose‐dependent way. These effects correlated with marked downregulation of CD40, p‐AKT, p‐mTOR, p‐p65 and p52 expression. Conversely, activation of CD40 signalling with sCD40L promoted EC cell malignancy and overturned the anti‐tumour effects of SA on EC cells. Additionally, SA treatment suppressed tumour growth in xenograft mouse models, along with reduced levels of Ki67, CD40, p‐AKT, p‐mTOR, p‐p65 and p52 in mouse tumour tissues, which were counteracted by sCD40L co‐treatment. SA effectively suppresses endometrial carcinoma progression by targeting the CD40‐AKT‐NF‐κB pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Medicine, Macau University of Science and Technology, Macau, China.
- Department of Gynecology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
ORCID-Profile: Weiping Chen
Förderung
- Macau University of Science and Technology Research Fund
Zitieren
APA
Zhang, C., Liu, Q., Bi, L., Chen, W., & Zeng, L. (2025). Salvianolic Acid A From Salvia miltiorrhiza Suppresses Endometrial Carcinoma Progression via CD40 ‐ AKT ‐ NF ‐ κB Pathway. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.70017
Vancouver
Zhang C, Liu Q, Bi L, Chen W, Zeng L. Salvianolic Acid A From Salvia miltiorrhiza Suppresses Endometrial Carcinoma Progression via CD40 ‐ AKT ‐ NF ‐ κB Pathway. Scandinavian Journal of Immunology. 2025. doi:10.1111/sji.70017
BibTeX
@article{Zhang2025,
author = {Zhang, Chunhua and Liu, Qing and Bi, Lei and Chen, Weiping and Zeng, Li},
title = {Salvianolic Acid A From Salvia miltiorrhiza Suppresses Endometrial Carcinoma Progression via CD40 ‐ AKT ‐ NF ‐ κB Pathway},
journal = {Scandinavian Journal of Immunology},
year = {2025},
doi = {10.1111/sji.70017}
}
EUVIMED